{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:52:19Z","timestamp":1789692739401,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s42770-024-01568-8","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T13:11:13Z","timestamp":1733317873000},"page":"499-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of COVID-19 pandemic on antimicrobial resistance of Proteus mirabilis in a Brazilian hospital"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2959-5666","authenticated-orcid":false,"given":"Luana Karolyne Salom\u00e3o","family":"de Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-0840","authenticated-orcid":false,"given":"Luana Carvalho","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-5387","authenticated-orcid":false,"given":"Gustavo Henrique Migliorini","family":"Guidone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-4621","authenticated-orcid":false,"given":"Bruno Henrique Dias","family":"de Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-4694","authenticated-orcid":false,"given":"Arthur Bossi","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5855-8746","authenticated-orcid":false,"given":"Gabriela","family":"Faustino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"da Silva Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3345-153X","authenticated-orcid":false,"given":"Eliana Carolina","family":"Vespero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-536X","authenticated-orcid":false,"given":"Sergio Paulo Dejato","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"1568_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"JN FLORES-MIRELES AL, WALKER","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13:269\u2013284. https:\/\/doi.org\/10.1038\/nrmicro3432","journal-title":"Nat Rev Microbiol"},{"key":"1568_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MRM.0000000000000144","volume":"29","author":"S SHIRALIZADEH","year":"2018","unstructured":"Shiralizadeh S, Taghizadeh S, Asgharzadeh M, Shokouhi B, Rahbar Gholizadehp, M., Samadi, H. K (2018) Urinary tract infections: raising problem in developing countries. Med Microbiol 29:159\u2013165. https:\/\/doi.org\/10.1097\/MRM.0000000000000144","journal-title":"Med Microbiol"},{"key":"1568_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.amjopharm.2011.07.002","volume":"9","author":"SJ MATTHEWS","year":"2011","unstructured":"Matthews SJ, Lancaster, J. W (2011) Urinary tract infections in the elderly population. Am J Geriatr Pharmacother 9:286\u2013309. https:\/\/doi.org\/10.1016\/j.amjopharm.2011.07.002","journal-title":"Am J Geriatr Pharmacother"},{"key":"1568_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1756-0500-3-169","volume":"3","author":"A PAPAZAFIROPOULOU","year":"2010","unstructured":"Papazafiropoulou A, Daniil I, Sotiropoulos A, Balampani E, Kokolaki A, Bousboulas S, Konstantopoulou S, Skliros E, Petropoulou D, Pappas, S (2010) Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria. BMC Res Notes 3:169. https:\/\/doi.org\/10.1186\/1756-0500-3-169","journal-title":"BMC Res Notes"},{"key":"1568_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/CMR.00019-07","volume":"21","author":"SM JACOBSEN","year":"2008","unstructured":"Jacobsen SM, Stckler DJ, Mobley HLT, Shirtliff, M. E (2008) Complicated cateter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol 21:26\u201359. https:\/\/doi.org\/10.1128\/CMR.00019-07","journal-title":"Clin Microbiol"},{"key":"1568_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2165\/00002512-200522080-00001","volume":"22","author":"LE NICOLLE","year":"2005","unstructured":"Nicolle LE (2005) Catheter-related urinary tract infection. Drugs Aging 22:627\u2013639. https:\/\/doi.org\/10.2165\/00002512-200522080-00001","journal-title":"Drugs Aging"},{"key":"1568_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/sj.sc.3102004","volume":"45","author":"EW HUNG","year":"2007","unstructured":"Hung EW, Darouiche RO, Trautner BW (2007) Proteus bacteriuria is associated with significant morbidity in spinal cord injury. Spinal Cord 45:616\u2013620. https:\/\/doi.org\/10.1038\/sj.sc.3102004","journal-title":"Spinal Cord"},{"key":"1568_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1128\/cmr.13.4.534-546.2000","volume":"13","author":"CM O\u2019HARA","year":"2000","unstructured":"O\u2019hara CM (2000) Classification, identification, and clinical significance of Proteus, Providence, and Morganella. Clin Microbiol 13:534\u2013546. https:\/\/doi.org\/10.1128\/cmr.13.4.534-546.2000","journal-title":"Clin Microbiol"},{"key":"1568_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/ncpuro1231","volume":"5","author":"DJ STICKLER","year":"2008","unstructured":"Stickler DJ (2008) Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol 5:598\u2013608. https:\/\/doi.org\/10.1038\/ncpuro1231","journal-title":"Nat Clin Pract Urol"},{"key":"1568_CR10","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1128\/iai.60.11.4740-4746.1992","volume":"60","author":"C ALLISON","year":"1992","unstructured":"Allison C, Coleman N, Jones PL, Hughes C (1992) Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun 60:4740\u20134746. https:\/\/doi.org\/10.1128\/iai.60.11.4740-4746.1992","journal-title":"Infect Immun"},{"key":"1568_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1574-695X.2007.00308.x","volume":"51","author":"SP ROCHA","year":"2007","unstructured":"Rocha SP, Elias WP, Cianciarullo AM, Menezes MA, Nara, J. M., Pra\u00c7a, R. M. F., Silva, M. R. L., Moreira, C. G., Pelayo, J. S (2007) Aggregative adherence of uropathogenic Proteus mirabilis to cultured epitelial cells. FEMS Immunol Med Microbiol 51:319\u2013326. https:\/\/doi.org\/10.1111\/j.1574-695X.2007.00308.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1568_CR12","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1128\/IAI.72.9.5159-5167.2004","volume":"72","author":"R BELAS","year":"2004","unstructured":"Belas R, Suvanasuthi Manosj, R (2004) Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobiol peptides. Infect Immun 72:5159\u20135167. https:\/\/doi.org\/10.1128\/IAI.72.9.5159-5167.2004","journal-title":"Infect Immun"},{"key":"1568_CR13","doi-asserted-by":"publisher","unstructured":"Stock I (2003) Natural antibiotic susceptibility of Proteus spp., with special reference to P. Mirabilis and P. penneri strains. 15:12\u201326. https:\/\/doi.org\/10.1179\/joc.2003.15.1.12","DOI":"10.1179\/joc.2003.15.1.12"},{"key":"1568_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF01641355","volume":"11","author":"H KNOTHE","year":"1983","unstructured":"Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebisiella pneumoniae and Serratia marcescens. Infection 11:315\u2013317. https:\/\/doi.org\/10.1007\/BF01641355","journal-title":"Infection"},{"key":"1568_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/BF01650718","volume":"17","author":"A BAUERFEIND","year":"1989","unstructured":"Bauerfeind A, Chong Y, Schweighart S (1989) Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316\u2013321. https:\/\/doi.org\/10.1007\/BF01650718","journal-title":"Infection"},{"key":"1568_CR16","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.3389\/fmicb.2020.00256","volume":"21","author":"D GIRLICH","year":"2020","unstructured":"Girlich D, Dortet Bonninra, Naas L, T (2020) Genetics of Aquired Antibiotic Resistance genes in Proteus spp. Front Microbiol 21:11256. https:\/\/doi.org\/10.3389\/fmicb.2020.00256","journal-title":"Front Microbiol"},{"issue":"4","key":"1568_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/jac\/45.4.537","volume":"45","author":"C CHAMPS","year":"2000","unstructured":"Champs C, Bonnet R, Sirot D, Chanal C, Sirot J (2000) Clinical revelance of Proteus mirabilis in hospital patients: a two year suvey. J Antimic Chem 45(4):537\u2013539. https:\/\/doi.org\/10.1093\/jac\/45.4.537","journal-title":"J Antimic Chem"},{"issue":"2","key":"1568_CR18","doi-asserted-by":"publisher","first-page":"e87801","DOI":"10.1371\/journal.pone.0087801","volume":"6","author":"T GUILLARD","year":"2014","unstructured":"Guillard T, Grillon, A., Champs, C., et al (2014) Mobile insertion cassette elements found in small non-transmissible plasmids in Proteeae may explain qnrD mobilization. PLoS ONE 6(2):e87801. https:\/\/doi.org\/10.1371\/journal.pone.0087801","journal-title":"PLoS ONE"},{"key":"1568_CR19","doi-asserted-by":"publisher","first-page":"104642","DOI":"10.1016\/j.micpath.2020.104642","volume":"152","author":"WD OLIVEIRA","year":"2021","unstructured":"Oliveira WD, Faustino Barbozamgl, G., et al (2021) Virulence, resistance and clonality of Proteus mirabilis isolated from patients with community-acquired urinary tract infection (CA-UTI) in Brazil. Microb Pathog 152:104642. https:\/\/doi.org\/10.1016\/j.micpath.2020.104642","journal-title":"Microb Pathog"},{"issue":"3","key":"1568_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s42770-019-00086-2","volume":"50","author":"MS SANCHES","year":"2019","unstructured":"Sanches MS, Souza Baptistaaas, M., et al (2019) Genotypic and phenotypic profiles of virulence factors and Antimicrobial Resistance of Proteus mirabilis isolated from Chicken carcasses: potential zoonotic risk. Brazilian J Microbiol 50(3):685\u2013694. https:\/\/doi.org\/10.1007\/s42770-019-00086-2","journal-title":"Brazilian J Microbiol"},{"key":"1568_CR21","first-page":"125","volume":"10","author":"MK ISLAM","year":"2021","unstructured":"Islam MK (2021) Is the COVID19 pandemic accelerating the Existing Public Health Problem of Antimicrobial Resistance? Clin Microbiol 10:125","journal-title":"Clin Microbiol"},{"key":"1568_CR22","unstructured":"Centers for Disease Control and Prevention (2019) Coronav\u00edrus Disease 2019 (COVID-19)\u2013 Situation Summary. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/casesupdates\/summary.html?CDC_AA_refValhttps%3A%2F%2Fwww.cdc.gov%2Fcoron avirus%2F2019-ncov%2Fsummary.html"},{"key":"1568_CR23","doi-asserted-by":"publisher","first-page":"104364","DOI":"10.1016\/j.jcv.2020.104364","volume":"127","author":"G ZHANG","year":"2020","unstructured":"Zhang G, Luo Huc, Fang L, Chen F, Li Y, Peng J, Pan Z, H (2020) Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 127:104364. https:\/\/doi.org\/10.1016\/j.jcv.2020.104364","journal-title":"J Clin Virol"},{"key":"1568_CR24","doi-asserted-by":"publisher","first-page":"115094","DOI":"10.1016\/j.diagmicrobio.2020.115094","volume":"98","author":"K ORTIZ-PRADO E., SIMBA\u00d1A-RIVERA","year":"2020","unstructured":"Ortiz-Prado E., Simba\u00d1a-Rivera K, G\u00d3mez-Barreno L et al (2020) Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis 98:115094. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115094","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"1568_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1001\/jama.2016.11764","volume":"316","author":"HD MARSTON","year":"2016","unstructured":"Marston HD, Dixon DM, Knisely, J. M., et al (2016) Antimicrobial Resistance. Clin Rev Educ 316(11):1193\u20131204. https:\/\/doi.org\/10.1001\/jama.2016.11764","journal-title":"Clin Rev Educ"},{"issue":"4","key":"1568_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1590\/S1517-83822014000400037","volume":"45","author":"J KWIECINSKA-PRI\u00d3G","year":"2014","unstructured":"Kwiecinska-Pri\u00d3g J, Bogiel T, Skowron K, Wieckowska E, Gospodarek E (2014) Proteus mirabilis biofilm-qualitative and quantitative colorimetric methods-based evaluation. Brazilian J Microbiol 45(4):1423\u20131431. https:\/\/doi.org\/10.1590\/S1517-83822014000400037","journal-title":"Brazilian J Microbiol"},{"key":"1568_CR27","unstructured":"Clinical and Laboratory Standards Institute, CLSI (2023) Performance standards for Antimicrobial susceptibility testing. Clin Lab Stand Inst 33\u2013 ed. M100. CLSI"},{"issue":"3","key":"1568_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP MAGIORAKOS","year":"2012","unstructured":"Magiorakos AP, Srinivasanb A, Carey, R. B., et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1568_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/jac\/dki412","volume":"57","author":"N WOODFORD","year":"2006","unstructured":"Woodford N, Ellington Faganej, M. J (2006) Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum B-lactamases. J Antimicrob Chemoterapy 57(1):154\u2013155. https:\/\/doi.org\/10.1093\/jac\/dki412","journal-title":"J Antimicrob Chemoterapy"},{"key":"1568_CR30","doi-asserted-by":"publisher","unstructured":"P\u00c9rez-P\u00c9rez FJ, Hanson, N. D (2002) Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40(6). https:\/\/doi.org\/10.1128\/jcm.40.6.2153-2162.2002","DOI":"10.1128\/jcm.40.6.2153-2162.2002"},{"issue":"6","key":"1568_CR31","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/j.1365-2672.2007.03470.x","volume":"103","author":"Q LI","year":"2007","unstructured":"Li Q, Logue Sherwoodjs, C. M (2007) Characterization of antimicrobial resistant Escherichia coli isolated from processed bison carcasses. J Appl Microbiol 103(6):2361\u20132369. https:\/\/doi.org\/10.1111\/j.1365-2672.2007.03470.x","journal-title":"J Appl Microbiol"},{"issue":"2","key":"1568_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/AAC.00997-08","volume":"53","author":"LM CAVACO","year":"2009","unstructured":"Cavaco LM, Hasman H, Xia S, Aerestrup FM (2009) qnrD. Aarestrup, a novel gene conferring transferable quinolone resistance in Salmonella enterica Serovar Kentucky and bovismorbificans strains of human origin. Antimicrob Agents Chemother 53(2):603\u2013608. https:\/\/doi.org\/10.1128\/AAC.00997-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1568_CR33","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1128\/AAC.06191-11","volume":"56","author":"X CHEN","year":"2012","unstructured":"Chen X, Yin Zhangwpanw, Pan J, Gao Z, S., Jiao, X (2012) Prevalence of qnr, aac (6\u2019)-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and the environment. Antimicrob Agents Chemother 56(6):3423\u20133427. https:\/\/doi.org\/10.1128\/AAC.06191-11","journal-title":"Antimicrob Agents Chemother"},{"key":"1568_CR34","doi-asserted-by":"publisher","unstructured":"Mlynarcik P, Roderova M, Kolar M (2016) Primer evaluation for PCR and its application for detection of carbapenemases in Enterobacteriaceae. 9(1):e29314. https:\/\/doi.org\/10.5812\/jjm.29314","DOI":"10.5812\/jjm.29314"},{"issue":"10","key":"1568_CR35","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1128\/IAI.69.10.6209-6216.2001","volume":"69","author":"TA RUSSO","year":"2001","unstructured":"Russo TA, Carlino, U. B., Johnson, J. R (2001) Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli. Mol Pathogenesis 69(10):6209\u20139216. https:\/\/doi.org\/10.1128\/IAI.69.10.6209-6216.2001","journal-title":"Mol Pathogenesis"},{"issue":"2","key":"1568_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1128\/jb.175.2.457-464.1993","volume":"175","author":"FK BAHRANI","year":"1993","unstructured":"Bahrani FK, Mobley HLT (1993) Proteus mirabilis MR\/P fimbriae: molecular cloning, expression., and nucleotide sequence of the major fimbrial subunit gene. J Bacteriol 175(2):457\u2013464. https:\/\/doi.org\/10.1128\/jb.175.2.457-464.1993","journal-title":"J Bacteriol"},{"issue":"12","key":"1568_CR37","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1128\/iai.67.12.6683-6687.1999","volume":"67","author":"DE JOHNSON","year":"1999","unstructured":"Johnson De, Bahrani FK, Lockatell CV, Drachenberg CB, Mobley Hebeljrbelasrwarrenjw, H. L. T (1999) Serum immunoglobulin response and protection from homologus challenge by Proteus mirabilis in a mouse model of ascending urinary tract infection. Infect Immun 67(12):6683\u20136687. https:\/\/doi.org\/10.1128\/iai.67.12.6683-6687.1999","journal-title":"Infect Immun"},{"issue":"1","key":"1568_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/iai.54.1.43-49.1986","volume":"54","author":"SK WRAY","year":"1986","unstructured":"Wray SK, Hull SI, Cook RG, Barrish, J., Hull, R. A (1986) Identification and characterization of a uroepitelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Infect Immun 54(1):43\u201349. https:\/\/doi.org\/10.1128\/iai.54.1.43-49.1986","journal-title":"Infect Immun"},{"issue":"5","key":"1568_CR39","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1128\/iai.62.5.1989-1994.1994","volume":"62","author":"G MASSAD","year":"1994","unstructured":"Massad G, Bahrani FK, Mobley HL (1994) Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambiente-temperature fimbria. Infect Immun 62(5):1989\u20131994. https:\/\/doi.org\/10.1128\/iai.62.5.1989-1994.1994","journal-title":"Infect Immun"},{"issue":"4","key":"1568_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1365-2958.2008.06199.x","volume":"68","author":"P ALAMURI","year":"2008","unstructured":"Alamuri P, Mobley HLT (2008) Anovel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and na agglutinin. Mol Microbiol 68(4):997\u20131017. https:\/\/doi.org\/10.1111\/j.1365-2958.2008.06199.x","journal-title":"Mol Microbiol"},{"issue":"20","key":"1568_CR41","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1128\/jb.177.20.5790-5798.1995","volume":"177","author":"C WASSIF","year":"1995","unstructured":"Wassif C, Cheek D, Belas R (1995) Molecular analysis of a metalloprotease from Proteus mirabilis. J Bacteriol 177(20):5790\u20135798. https:\/\/doi.org\/10.1128\/jb.177.20.5790-5798.1995","journal-title":"J Bacteriol"},{"issue":"6","key":"1568_CR42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00284-013-0423-5","volume":"67","author":"SE CESTARI","year":"2013","unstructured":"Cestari SE, Ludovico MS, Rocha Martinsfh, S. P. D., Elias, W. P., Pelayo, J. S (2013) Molecular detection of HpmA and HlyA hemolysin of uropathogenic Proteus mirabilis. Curr Microbiol 67(6):703\u2013707. https:\/\/doi.org\/10.1007\/s00284-013-0423-5","journal-title":"Curr Microbiol"},{"key":"1568_CR43","doi-asserted-by":"publisher","first-page":"105098","DOI":"10.1016\/j.micpath.2021.105098","volume":"158","author":"MS SANCHES","year":"2021","unstructured":"Sanches MS, Silva CR, SILVA LC et al (2021) Proteus mirabilis from Community-acquired urinary tract infections (UTI-CA) shares genetic similar and virulence factors with isolates from Chicken, beef and pork meat. Microb Pathog 158:105098. https:\/\/doi.org\/10.1016\/j.micpath.2021.105098","journal-title":"Microb Pathog"},{"key":"1568_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1186\/s12879-022-07885-3","volume":"22","author":"JM MUTUA","year":"2022","unstructured":"Mutua JM, Musyoki Njerujm, A. M (2022) Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya. BMC Infect Dis 22:877. https:\/\/doi.org\/10.1186\/s12879-022-07885-3","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1568_CR45","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.3390\/jcm12237278","volume":"12","author":"F GAVI","year":"2023","unstructured":"Gavi F, Fiori B, Gandi, C., Campetella, M., et al (2023) Prevalence and Antimicrobial Resistance patterns of Hospital Acquired infections through the COVID-19 pandemic: real-word data from a tertiary urological centre. J Clin Med 12(3):7278. https:\/\/doi.org\/10.3390\/jcm12237278","journal-title":"J Clin Med"},{"issue":"4","key":"1568_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/antibiotics10040447","volume":"10","author":"B KOT","year":"2021","unstructured":"Kot B, Szweda Gruzewskaa, Wicha P, J., Parulska, U (2021) Antibiotic resistance of uropathogens isolated from patients hospitalized in district hospital in central Poland in 2020. Antibiot (Basel) 10(4):447. https:\/\/doi.org\/10.3390\/antibiotics10040447","journal-title":"Antibiot (Basel)"},{"issue":"3","key":"1568_CR47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.26502\/acbr.50170257","volume":"6","author":"NJ MISHU","year":"2022","unstructured":"Mishu NJ, Shamsuzzaman SM, Khaleduzzaman HM et al (2022) Association between biofilm formation and virulence genes expression. And antibiotic resistance pattern in Proteus mirabilis, isolated from patients of Dhaka Medical College Hospital. Arch Clin Biomed Res 6(3):418\u2013434. https:\/\/doi.org\/10.26502\/acbr.50170257","journal-title":"Arch Clin Biomed Res"},{"issue":"3","key":"1568_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jiph.2022.12.022","volume":"16","author":"U ABUBAKAR","year":"2023","unstructured":"Abubakar U, AL-Anazi M, Alanazi Z, Rodr\u00cdguez-Ba\u00d1o J (2023) Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review. J Infect Public Health 16(3):320\u2013331. https:\/\/doi.org\/10.1016\/j.jiph.2022.12.022","journal-title":"J Infect Public Health"},{"issue":"4","key":"1568_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QCO.0000000000000735","volume":"34","author":"LS JIN","year":"2021","unstructured":"Jin LS, Fisher D (2021) Mdro transmission in acute hospitals during the COVID-19 pandemic. Curr Opin Infect Dis 34(4):365\u2013371. https:\/\/doi.org\/10.1097\/QCO.0000000000000735","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"1568_CR50","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/microorganisms10071314","volume":"10","author":"E GIANNITSIOTI","year":"2022","unstructured":"Giannitsioti E, Louka C, Mamali V, Kousouli, E., et al (2022) Bloodstream Infections in a COVID-19 Non-ICU Department: Microbial Epidemiology, Resistance profiles and comparative analysis of risk factors and patients\u2019 outcome. Microorganisms 10(7):1314. https:\/\/doi.org\/10.3390\/microorganisms10071314","journal-title":"Microorganisms"},{"issue":"1","key":"1568_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13756-022-01052-8","volume":"11","author":"R THOMA","year":"2022","unstructured":"Thoma R, Seneghini M, Gysin Seiffertsn, D. V., et al (2022) The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida Auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control 11(1):12. https:\/\/doi.org\/10.1186\/s13756-022-01052-8","journal-title":"Antimicrob Resist Infect Control"},{"key":"1568_CR52","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.2147\/IDR.S421240","volume":"16","author":"Y GENG","year":"2023","unstructured":"Geng Y, Li F, Chen, C., LIU, Z., et al (2023) Increased incidence and risk factors of infections by extended-spectrum \u03b2-Lactamase-producing enterobacterales during the COVID-19 pandemic: a retrospective case-control study. Infect Drug Resist 16:4704\u20134716. https:\/\/doi.org\/10.2147\/IDR.S421240","journal-title":"Infect Drug Resist"},{"issue":"1","key":"1568_CR53","doi-asserted-by":"publisher","first-page":"e0312422","DOI":"10.1128\/spectrum.03124-22","volume":"11","author":"MR HASAN","year":"2023","unstructured":"Hasan MR, Vincent YM, Leto D, Almohri H (2023) Trends in the rates of extended-Spectrum-\u03b2-Lactamase-producing enterobacterales isolated from urine cultures during the COVID-19 pandemic in Ontario, Canada. Spectr Microbiol 11(1):e0312422. https:\/\/doi.org\/10.1128\/spectrum.03124-22","journal-title":"Spectr Microbiol"},{"key":"1568_CR54","unstructured":"World Health Organization (2021) COVID-19 Clinical management: living guidance. Dispon\u00edvel em: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2021-1"},{"issue":"1","key":"1568_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.37777\/dscs.v23n1-005","volume":"23","author":"JF FRIEDRICH","year":"2022","unstructured":"Friedrich JF, Cunha RSR, Wallauer CM, Steffen, A. C. H (2022) Perfil De infec\u00e7\u00f5es bacterianas em pacientes com COVID-19 em uma unidade de terapia intensiva. Disciplinarum Scientia 23(1):47\u201363. https:\/\/doi.org\/10.37777\/dscs.v23n1-005","journal-title":"Disciplinarum Scientia"},{"issue":"4","key":"1568_CR56","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10096-020-04063-8","volume":"40","author":"K ROTHE","year":"2021","unstructured":"Rothe K, Feihl S, Schneider, J., Walln\u00d6fer, F., et al (2021) Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis 40(4):859\u2013869. https:\/\/doi.org\/10.1007\/s10096-020-04063-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"1568_CR57","doi-asserted-by":"publisher","first-page":"dlaa071","DOI":"10.1093\/jacamr\/dlaa071","volume":"2","author":"L TOWNSEND","year":"2020","unstructured":"Townsend L, Hughes G, Kerr C, Kelly M et al (2020) Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC-Antimicrobial Resist 2(3):dlaa071. https:\/\/doi.org\/10.1093\/jacamr\/dlaa071","journal-title":"JAC-Antimicrobial Resist"},{"key":"1568_CR58","unstructured":"Organiza\u00e7\u00e3o Pan-Americana da Sa\u00fade (2017) OMS publica lista de bact\u00e9rias para as quais se necessitam novos antibi\u00f3ticos urgentemente. https:\/\/www.paho.org\/pt\/noticias\/27-2-2017-oms-publica-lista-bacterias-para-quais-se-necessitam-novos-antibioticos"},{"issue":"11","key":"1568_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid2811.220415","volume":"28","author":"GR THOMAS","year":"2022","unstructured":"Thomas GR, Corso A, Paster\u00c1N F et al (2022) Increased detection of carbapenemase-producing enterobacterales bacteria in Latin America and the Caribbean during the COVID-19 pandemic. Emerg Infect Dis 28(11):1\u20138. https:\/\/doi.org\/10.3201\/eid2811.220415","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"1568_CR60","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jac\/dkaa466","volume":"76","author":"A GOMEZ-SIMMONDS","year":"2021","unstructured":"Gomez-Simmonds A, Mcconville Annavajhalamk, T. H., et al (2021) Carbapenemase-producing enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital. J Antimicrob Chemother 76(2):380\u2013384. https:\/\/doi.org\/10.1093\/jac\/dkaa466","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1568_CR61","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/1469-0691.12322","volume":"20","author":"K VAN DIJK","year":"2014","unstructured":"Van Dijk K, Voets GM, Scharringa, J., et al (2014) A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boric acid, dipcolinic acid and temocillin. Clin Microbiol Infect 20(4):345\u2013349. https:\/\/doi.org\/10.1111\/1469-0691.12322","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1568_CR62","doi-asserted-by":"publisher","first-page":"e01697","DOI":"10.1128\/AAC.01697-16","volume":"61","author":"D GIRLICH","year":"2017","unstructured":"Girlich D, Bonni, R. A., Bogaerts, et al (2017) Chromosomal amplification of the blaOXA-58 carbapenemase gene in a Proteus mirabilis clinical isolate. Antimicrob Agents Chemother 61(2):e01697\u2013e01616. https:\/\/doi.org\/10.1128\/AAC.01697-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1568_CR63","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3390\/medicina59101763","volume":"59","author":"D GARCIA-CEDR\u00d3N","year":"2023","unstructured":"Garcia-Cedr\u00d3n D, Cabanillas-Chirinos Noriegamc, L., et al (2023) Carbapenemase-producing bacteria isolated from ICU patients of a Peruvian government hospital during the COVID-19 pandemic: a descriptive analysis. Medicina 59(10):1763. https:\/\/doi.org\/10.3390\/medicina59101763","journal-title":"Medicina"},{"key":"1568_CR64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12866-022-02662-3","volume":"22","author":"M SHAABAN","year":"2022","unstructured":"Shaaban M, Elshaer SL, EL-Rahman A (2022) Prevalence of extended\u2013spectrum \u03b2\u2013lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates. BMC Microbiol 22:247. https:\/\/doi.org\/10.1186\/s12866-022-02662-3","journal-title":"BMC Microbiol"},{"key":"1568_CR65","first-page":"599","volume":"608","author":"KMM MONGE","year":"2013","unstructured":"Monge KMM (2013) Carbapen\u00eamicos: tipos y mecanismos de resist\u00eancia bacterianos. Rev Med Costa Rica Y Centroamericana 608:599\u2013605","journal-title":"Rev Med Costa Rica Y Centroamericana"},{"issue":"1","key":"1568_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33448\/rsd-v11i1.25035","volume":"11","author":"MS FREIRES","year":"2022","unstructured":"Freires MS, Junior, O. M. R (2022) Bacterial resistance to indiscriminate use of azithromycin versus Covid-19: na integrative review. Res Soc Dev 11(1):1\u201310. https:\/\/doi.org\/10.33448\/rsd-v11i1.25035","journal-title":"Res Soc Dev"},{"issue":"1","key":"1568_CR67","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12917-020-02372-w","volume":"16","author":"Y SUN","year":"2020","unstructured":"Sun Y, Wen S, Zhao, L., et al (2020) Associations among biofilm formation, virulence gene expression., and antibiotic resistance in Proteus mirabilis isolates from diarrhetic animal in Northeast China. BMC Vet Res 16(1):176. https:\/\/doi.org\/10.1186\/s12917-020-02372-w","journal-title":"BMC Vet Res"},{"issue":"6","key":"1568_CR68","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/23744235.2015.1129551","volume":"48","author":"A KORYTNY","year":"2016","unstructured":"Korytny A, Riesenberg K, Saidel-Odes L, Schlaeffer F, Borer, A (2016) Bloodstream infections caused by multi-drug resistant Proteus mirabilis: Epidemiology, risk factors and impacto f multi-drug resistance. Infect Dis 48(6):428\u2013431. https:\/\/doi.org\/10.3109\/23744235.2015.1129551","journal-title":"Infect Dis"},{"key":"1568_CR69","doi-asserted-by":"publisher","unstructured":"Armbuster CE, Mobley HT, Pearson MM (2018) Pathogenesis of Proteus mirabilis infection. EcoSalPlus 8(1). https:\/\/doi.org\/10.1128\/.ecosalplus.ESP-0009-2017","DOI":"10.1128\/.ecosalplus.ESP-0009-2017"},{"key":"1568_CR70","doi-asserted-by":"crossref","unstructured":"Schaffer JN, Pearson, M. M (2017) Proteus mirabilis and urinary tract infections. Urinary tract infections: Molecular Pathogenesis and Clinical Management, 2\u2013 edn. ed. American Society for Microbiology","DOI":"10.1128\/9781555817404.ch17"},{"issue":"11","key":"1568_CR71","doi-asserted-by":"publisher","first-page":"e19121143608","DOI":"10.33448\/rsd-v12i11.43608","volume":"12","author":"SJV OLIVEIRA","year":"2023","unstructured":"Oliveira SJV, Santiago MAA, Lisboa LFT, Gris\u00d3lia DPA, Costa CMM, Gris\u00d3lia ABA (2023) Atua\u00e7\u00e3o do farmac\u00eautico na promo\u00e7\u00e3o do uso racional de antibi\u00f3tico no \u00e2mbito hospitalar: Uma revis\u00e3o integrativa. Res Soc Dev 12(11):e19121143608. https:\/\/doi.org\/10.33448\/rsd-v12i11.43608","journal-title":"Res Soc Dev"},{"key":"1568_CR72","doi-asserted-by":"publisher","first-page":"e202110203","DOI":"10.1590\/2177-9465-EAN-2021-0203","volume":"26","author":"L PONTES","year":"2022","unstructured":"Pontes L, Danski MTR, Piubello SMN et al (2022) Clinical profile and factors associated with the death of COVID-19 patients in the first months of the pandemic. Esc Anna Nery 26:e202110203. https:\/\/doi.org\/10.1590\/2177-9465-EAN-2021-0203","journal-title":"Esc Anna Nery"},{"key":"1568_CR73","doi-asserted-by":"publisher","unstructured":"Rebou\u00c7as Ern, Costa, R. F., Miranda, L. R., Campos, N. G (2020) J Health Biol Sci 8(1):1\u20135. Perfil demogr\u00e1fico e clinico de paciente com diagnostico de COVID-19 em um hospital p\u00fablico de refer\u00eancia na cidade de Fortaleza-Cear\u00e1 https:\/\/doi.org\/10.12662\/2317-3076jhbs.v8i1.3438.p1-5.2020","DOI":"10.12662\/2317-3076jhbs.v8i1.3438.p1-5.2020"},{"issue":"1","key":"1568_CR74","first-page":"33","volume":"32","author":"PP AGUIAR","year":"2020","unstructured":"Aguiar PP, Pereira Armondlca, Gomides PS, L. F (2020) Os riscos da Klebsiella pneumoniae em ambientes hospitalares. Braz J SurgClin Res 32(1):33\u201340","journal-title":"Braz J SurgClin Res"},{"issue":"9","key":"1568_CR75","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM RAWSON","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N et al (2020) A bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 71(9):2459\u20132468. https:\/\/doi.org\/10.1093\/cid\/ciaa530","journal-title":"Clin Infect Dis"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01568-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-024-01568-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01568-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T14:05:10Z","timestamp":1741269910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-024-01568-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1568"],"URL":"https:\/\/doi.org\/10.1007\/s42770-024-01568-8","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of patients\u2019 clinical and demographic data was approved by the Ethics and Research Committee of the Universidade Estadual de Londrina CAAE 28316819.0.0000.5231.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}